Denka Co Ltd 2018 IR
The report outlines Denka's transition to its new 'Denka Value-Up' management plan for fiscal 2018-2022, aiming to become a specialty-fusion company. Key achievements in fiscal 2017 include raising operating income in growth fields like healthcare, environment, and energy to 16.7 billion yen. The company also made progress in its clean energy initiatives, continuing the construction of two new hydroelectric power plants to reduce CO2 emissions. Additionally, Denka Seiken acquired FDA 510k clearance for its sd LDL-C diagnostic reagent, expanding its global healthcare presence.
Company: Denka Co Ltd
Sector: Materials
Country: Japan
Year: 2018
Type: IR
Pages: 30
Denka Co Ltd
Integrated Report
The report outlines Denka's transition to its new 'Denka Value-Up' management plan for fiscal 2018-2022, aiming to become a specialty-fusion company. Key achievements in fiscal 2017 include raising operating income in growth fields like healthcare, environment, and energy to 16.7 billion yen. The company also made progress in its clean energy initiatives, continuing the construction of two new hydroelectric power plants to reduce CO2 emissions. Additionally, Denka Seiken acquired FDA 510k clearance for its sd LDL-C diagnostic reagent, expanding its global healthcare presence.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Workplace Fatalities
Employees